RT Journal Article
SR Electronic
T1 Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.06.20227215
DO 10.1101/2020.11.06.20227215
A1 Anderson, Elizabeth M.
A1 Goodwin, Eileen C.
A1 Verma, Anurag
A1 Arevalo, Claudia P.
A1 Bolton, Marcus J.
A1 Weirick, Madison E.
A1 Gouma, Sigrid
A1 McAllister, Christopher M.
A1 Christensen, Shannon R.
A1 Weaver, JoEllen
A1 Hicks, Phillip
A1 Manzoni, Tomaz B.
A1 Oniyide, Oluwatosin
A1 Ramage, Holly
A1 Mathew, Divij
A1 Baxter, Amy E.
A1 Oldridge, Derek A.
A1 Greenplate, Allison R.
A1 Wu, Jennifer E.
A1 Alanio, Cécile
A1 D’Andrea, Kurt
A1 Kuthuru, Oliva
A1 Dougherty, Jeanette
A1 Pattekar, Ajinkya
A1 Kim, Justin
A1 Han, Nicholas
A1 Apostolidis, Sokratis A.
A1 Huang, Alex C.
A1 Vella, Laura A.
A1 ,
A1 Wherry, E. John
A1 Meyer, Nuala J.
A1 Cherry, Sara
A1 Bates, Paul
A1 Rader, Daniel J.
A1 Hensley, Scott E.
YR 2020
UL http://medrxiv.org/content/early/2020/11/10/2020.11.06.20227215.abstract
AB Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread within the human population. Although SARS-CoV-2 is a novel coronavirus, most humans had been previously exposed to other antigenically distinct common seasonal human coronaviruses (hCoVs) before the COVID-19 pandemic. Here, we quantified levels of SARS-CoV-2-reactive antibodies and hCoV-reactive antibodies in serum samples collected from 204 humans before the COVID-19 pandemic. We then quantified pre-pandemic antibody levels in serum from a separate cohort of 252 individuals who became PCR-confirmed infected with SARS-CoV-2. Finally, we longitudinally measured hCoV and SARS-CoV-2 antibodies in the serum of hospitalized COVID-19 patients. Our studies indicate that most individuals possessed hCoV-reactive antibodies before the COVID-19 pandemic. We determined that ∼23% of these individuals possessed non-neutralizing antibodies that cross-reacted with SARS-CoV-2 spike and nucleocapsid proteins. These antibodies were not associated with protection against SARS-CoV-2 infections or hospitalizations, but paradoxically these hCoV cross-reactive antibodies were boosted upon SARS-CoV-2 infection.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialleftover samples from other studies, no trial IDFunding StatementEMA and TBM were supported by the NIH Training in Virology T32 Program through grant number T32-AI-007324. PH was supported by the NIH Emerging Infectious Diseases T32 Program T32-AI055400. PB was supported by a Peer Reviewed Medical Research Program award PR182551 and grants from the NIH (R21AI129531 and R21AI142638). This work was supported by institutional funds from the University of Pennsylvania and NIH HL137006 (NJM) and HL137915 (NJM). We thank J. Lurie, J. Embiid, J. Harris, and D. Blitzer for philanthropic support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All studies were approved by the University of Pennsylvania Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe article includes all data generated or analyzed during this study.